Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,762.00    -3.00 (-0.17%)
Bid:
1,766.00
Ask:
1,769.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Charlotte Building Announcement

25 Aug 2010 07:01

RNS Number : 5770R
Derwent London PLC
25 August 2010
 

 

 

25 August 2010

 

 

Derwent London plc ("Derwent London" / "Company")

 

DERWENT LONDON ANNOUNCES CHARLOTTE BUILDING,

LONDON W1, FULLY LET

 

Derwent London is pleased to announce that the Charlotte Building, 17 Gresse Street, London W1, is now fully let following the 7,400 sq ft (690 sq m) letting to LinkedIn Europe Ltd, an Internet platform company focussed on connecting the world's business professionals.

 

LinkedIn has taken the entire first floor on a 10-year lease at a rent of £0.35 million per annum (£47.50 per sq ft / £510 per sq m) with an option to break after five years. They will join Converse, Unanimis, Icon Entertainment and Brandopus as tenants in the building.

 

The 47,000 sq ft (4,400 sq m) Charlotte Building is set over seven floors around a landscaped courtyard and is the work of architects Lifschutz Davidson Sandilands. It was completed in October 2009 and has already been recognised with two prestigious awards - the British Council for Offices award for Best Commercial Workplace in London and the South East and the Royal Institute of British Architects award for architectural excellence in London.

 

John Burns, Chief Executive, Derwent London, commented:

 

"We are delighted to welcome another progressive company to the Charlotte Building. This new development is a good example of our design-led regeneration work, replacing an inefficient, out-dated building with exciting new offices set within attractive public realm. We are pleased that rental levels have moved forward from the initial letting and that tenant incentives have reduced. The building is located adjacent to our recent Central Cross acquisition, just to the north of Oxford Street. This is a locality in which Derwent London has major holdings and one which we have identified as offering significant growth."

 

 

 

-ends-

 

 

For further information please contact:

 

John Burns, Chief Executive, Derwent London: Tel - 020 7659 3000

James Rossiter, Kate Holgate, Brunswick Group: Tel - 020 7404 5959

 

 

 

 

Notes to editors:

 

Derwent London plc

 

Derwent London plc is the largest central London focused REIT with an investment portfolio of £2.15bn as at 30 June 2010. The group is one of London's most innovative office specialist property regenerators and investors and is well known for its established design-led philosophy and creative management approach to development.

 

Derwent London's core strategy is to acquire and own a portfolio of central London property that has reversionary rents and significant opportunities to enhance and extract value through refurbishment, regeneration and redevelopment. The group owns and manages an investment portfolio of 5.1m sq ft (475,600 sq m), as of 30 June 2010, of which 95% is located in central London, with a specific focus on the West End and the areas bordering the City of London. Landmark schemes by Derwent London include: Arup Phases II & III W1, Qube W1, Horseferry House SW1, Johnson Building EC1, Davidson Building WC2 and Tea Building E1.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKPLAALEEFF
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20262:00 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:37 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20265:15 pmRNSDirector/PDMR Shareholding
19th May 202610:00 amRNSDirector Declaration
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202611:45 amRNSResult of AGM
12th May 20267:00 amRNSTrading Statement
1st May 202610:30 amRNSHolding(s) in Company
30th Apr 20264:45 pmRNSTotal Voting Rights
22nd Apr 20265:00 pmRNSHolding(s) in Company
22nd Apr 202610:15 amRNSHolding(s) in Company
20th Apr 202610:30 amRNSHolding(s) in Company
14th Apr 202611:14 amRNSAnnual Financial Report
10th Apr 20264:45 pmRNSAdmission to Trading
7th Apr 20265:12 pmRNSEmployee Benefit Trust (“EBT”)
7th Apr 20264:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSAppointment of Barclays as joint corporate broker
1st Apr 20267:00 amRNSDisposal of Horseferry House SW1
31st Mar 20264:45 pmRNSTotal Voting Rights
27th Mar 202612:45 pmRNSDirector/PDMR Shareholding
24th Mar 202610:30 amRNSDirector/PDMR Shareholding
20th Mar 20264:15 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSNetwork building fully pre-let
16th Mar 20267:00 amRNSNetwork building fully pre-let
27th Feb 20264:45 pmRNSTotal Voting Rights
26th Feb 20267:32 amRNSDerwent London plc Disposal of 90 Whitfield Street
26th Feb 20267:00 amRNSResults for the Year Ended 31 December 2025
6th Feb 20264:40 pmRNSHolding(s) in Company
6th Feb 20267:00 amRNSDisposal of 80-85 Tottenham Court Road W1
30th Jan 20264:45 pmRNSTotal Voting Rights
22nd Jan 20269:00 amRNSDirectorate change
15th Jan 202611:00 amRNSHolding(s) in Company
31st Dec 20251:15 pmRNSTotal Voting Rights
31st Dec 20251:15 pmRNSTotal Voting Rights
17th Dec 20257:00 amRNSPlanning success at Blue Star House SW9
9th Dec 20257:00 amRNSBurberry extends commitment to Horseferry House
28th Nov 20254:45 pmRNSTotal Voting Rights
6th Nov 20257:00 amRNSThird Quarter Business Update
31st Oct 20254:45 pmRNSTotal Voting Rights
21st Oct 20257:00 amRNSStrategic partnership at Old Street Quarter
9th Oct 20257:00 amRNSSuccessful completion of 25 Baker Street
30th Sep 20254:45 pmRNSTotal Voting Rights
30th Sep 202511:00 amRNSHolding(s) in Company
22nd Sep 202512:00 pmRNSBlock listing Interim Review
9th Sep 202511:45 amRNSDirector Declaration
2nd Sep 202511:30 amRNSHolding(s) in Company
29th Aug 20254:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.